Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LUMOS PHARMA, INC. | Chief Medical Officer | Common Stock | 0 | $0 | $1.89 | Dec 12, 2024 | Direct |
LUMOS PHARMA, INC. | Chief Medical Officer | Stock Option (Right to Buy) | 0 | Dec 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
(LUMO) | LUMOS PHARMA, INC. | Dec 12, 2024 | 5 | $0 | 4 | Dec 13, 2024 | Chief Medical Officer |
(LUMO) | LUMOS PHARMA, INC. | Jul 1, 2024 | 1 | -$620 | 4 | Jul 3, 2024 | Chief Medical Officer |
(LUMO) | LUMOS PHARMA, INC. | Jun 1, 2024 | 1 | -$720 | 4 | Jun 4, 2024 | Chief Medical Officer |
(LUMO) | LUMOS PHARMA, INC. | Apr 1, 2024 | 2 | $17K | 4 | Apr 3, 2024 | Chief Medical Officer |
(LUMO) | LUMOS PHARMA, INC. | Jan 4, 2024 | 0 | $0 | 3 | Jan 10, 2024 | Chief Medical Officer |